TrialResults-center.org
Search
Menu
Home
Search
Recent trials
Browse pathology
Browse treatment
About us
LMWH
systematic review
meta-analysis
network meta-analysis
Ardeparin
-
Argatroban
-
Dalteparin
-
Enoxaparin
-
Logiparin
-
Nadroparin
Select
thrombosis prevention
venous thrombosis
abdominal surgery
All type of patient
general surgery
gynaecological surgery
medical patients
neurosurgery
orthopedic surgery
extended LMWH
home treatment
Low molecular weight heparin
once daily LMWH
unfractionated heparin
LMWH
ardeparin
Bemiparin
Certoparin
dalteparin
enoxaparin
fraxiparin
logiparin
nadroparin
reviparin
tinzaparin
UFH
vs LMWH
vs oral anticoagulant
vs placebo or control
vs placebo or no treatment
vs Dextran
vs twice daily LMWH
vs UFH
vs Unfractionated heparin
Filter
hide ongoing
show ongoing
hide ongoing
all ROB
Show all trials
Show only trial at low risk of bias
Hide exploratory trials
all results
Show all trials
Show only trial with conclusive result
Group by
Group by...
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
MA
in first
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in second
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in third
Description
Synopsis
Comparison
Treatments
Patients
Characteristics
Method
Risk of bias
References
None
Tools
Indexation
Results
Global trial result
Main results
All results
All result tag
NCT results
All cause death (93)
Major bleeding (85)
Symptomatic pulmonary embolism (84)
asymptomatic DVT (75)
wound haematoma / infection (73)
Bleeding (69)
transfusion (40)
Symptomatic venous thromboembolism (DVT, PE) (38)
Recurrent thromboembolic event (28)
Short term haemorrhage (17)
VTE during active anticoagulant treatment (13)
Thrombus extension (10)
Deep vein thrombosis (10)
pulmonary embolism (symptomatic and asymptomatic) (10)
VTE during follow-up after active anticoagulant treatment (7)
Minor bleeding (6)
Symptomatic deep-vein thrombosis (4)
major or clinically relevant non-major bleeding (3)
total VTE and all-cause mortality (3)
fatal pulmonary embolism (3)
puylmonary embolism (1)
recurrent DVT (1)
proximal deep-vein thrombosis (1)
Venous thromboembolism or death (1)
Options
Numeric
bar chart
forest plot
medians
Trial
Studied trt
Control trt
patients
tags
ROB
Trial result
All cause death
Major bleeding
thrombosis prevention
ardeparin
Levine, 1996
ardeparin
placebo
knee surgery
Low risk of bias
suggesting
Godwin, 1993
ardeparin
unfractionated heparin
abdominal surgery
-
Certoparin
CERTIFY, 2010
certoparin
UFH
medical patients
-
Schmitz-Huebner, 1984
certoparin
unfractionated heparin
abdominal surgery
negative
∞%
Sasahara, 1986
certoparin
unfractionated heparin
abdominal surgery
suggesting
-61%
Voigt, 1986
certoparin
unfractionated heparin
abdominal surgery
negative
-37%
183%
Welzel, 1988
certoparin
unfractionated heparin
abdominal surgery
suggesting
Kakkar, 1989
certoparin
unfractionated heparin
abdominal surgery
negative
∞%
Adolf, 1989
certoparin
unfractionated heparin
abdominal surgery
negative
Heilmann, 1989
certoparin
unfractionated heparin
gynaecological surgery
negative
-33%
Baumgartner, 1989
certoparin
unfractionated heparin
abdominal surgery
negative
-48%
Hoffmann and Largiade, 1990
certoparin
unfractionated heparin
abdominal surgery
negative
-3%
Koppenhagen, 1990
certoparin
unfractionated heparin
abdominal surgery
-
Schielke, 1991
certoparin
unfractionated heparin
abdominal surgery
-
Koppenhagen, 1992
certoparin
unfractionated heparin
abdominal surgery
-
Hoffmann and Largiader, 1992
certoparin
unfractionated heparin
abdominal surgery
-
Heilmann, 1997
certoparin
unfractionated heparin
gynaecological surgery
-
Haas, 1999
certoparin
unfractionated heparin
general surgery
-
Haas , 1987
certoparine + DHE
Unfractionated heparin
hip surgery
negative
Lassen, 1988
certoparine + DHE
Unfractionated heparin
hip surgery
Low risk of bias
suggesting
Lassen, 1989
certoparine + DHE
Unfractionated heparin
hip surgery
Low risk of bias
negative
109%
dalteparin
Jorgensen, 1989
dalteparin
placebo
hip surgery
Low risk of bias
suggesting
-100%
Torholm, 1991
dalteparin
placebo
hip surgery
Low risk of bias
suggesting
∞%
Ockelford , 1989
dalteparin
placebo
suggesting
-100%
-7%
Leizorovicz, 2004
dalteparin
placebo
medical patients
Low risk of bias
suggesting
2%
∞%
Eriksson , 1988
dalteparin
Dextran
hip surgery
suggesting
Matzsch , 1988
dalteparin
Dextran
hip surgery
negative
Matzsch , 1991
dalteparin
Dextran
hip surgery
suggesting
PROTECT, 2011
NCT
dalteparin
UFH
medical patients
Low risk of bias
suggesting
-10%
-2%
Haas , 1985
dalteparin
Unfractionated heparin
hip surgery
negative
Binsack , 1986
dalteparin
Unfractionated heparin
hip surgery
negative
Barre , 1987
dalteparin
Unfractionated heparin
hip surgery
negative
Dechavanne , 1989
dalteparin
Unfractionated heparin
hip surgery
negative
Eriksson , 1989
dalteparin
Unfractionated heparin
hip surgery
suggesting
-100%
Monreal , 1989
dalteparin
Unfractionated heparin
hip surgery
negative
-36%
Bergqvist, 1986
dalteparin
unfractionated heparin
abdominal surgery
negative
236%
Onarheim, 1986
dalteparin
unfractionated heparin
abdominal surgery
negative
8%
Koller, 1986
dalteparin
unfractionated heparin
abdominal surgery
negative
161%
Koller, 1986
dalteparin
unfractionated heparin
abdominal surgery
negative
∞%
Fricker, 1988
dalteparin
unfractionated heparin
abdominal surgery
negative
100%
Bergqvist, 1988
dalteparin
unfractionated heparin
abdominal surgery
negative
-2%
Caen, 1988
dalteparin
unfractionated heparin
abdominal surgery
negative
-35%
-100%
Borstad, 1988
dalteparin
unfractionated heparin
gynaecological surgery
negative
5%
Briel, 1988
dalteparin
unfractionated heparin
non orthopedic surgery
negative
Creperio, 1990
dalteparin
unfractionated heparin
general surgery
negative
Hartl, 1990
dalteparin
unfractionated heparin
abdominal surgery
suggesting
48%
-34%
Borstad, 1992
dalteparin
unfractionated heparin
gynaecological surgery
-
Kakkar, 1993
dalteparin
unfractionated heparin
abdominal surgery
-
enoxaparin
Warwick, 1995
enoxaparin
no treatment
hip surgery
negative
Ho [43]
enoxaparin
no treatment
negative
Turpie, 1986
enoxaparin
placebo
hip surgery
Low risk of bias
suggesting
-100%
Leclerc, 1991
enoxaparin
placebo
knee surgery
Low risk of bias
suggesting
Samama, 1997
enoxaparin
placebo
hip surgery
Low risk of bias
suggesting
Kalodiki, 1996
enoxaparin
placebo
hip surgery
Low risk of bias
-
Agnelli, 1998
enoxaparin
placebo
suggesting
Melon, 1987
enoxaparin
placebo
negative
MEDENOX, 1999
Enoxaparin
placebo
medical patients
Low risk of bias
suggesting
-26%
48%
Lederle, 2006
Enoxaparin
placebo
medical patients
Low risk of bias
negative
-60%
LIFENOX, 2011
NCT
enoxaparin
placebo
medical patients
Low risk of bias
negative
0%
40%
DES Group , 1991
enoxaparin
Dextran
hip surgery
suggesting
∞%
Bergmann and Neuhart, 1996
enoxaparin
UFH
medical patients
Low risk of bias
negative
-10%
Lechler, 1996
enoxaparin
UFH
medical patients
Low risk of bias
negative
-36%
Kleber, 2003
enoxaparin
UFH
medical patients
negative
-40%
Planes , 1988
enoxaparin
Unfractionated heparin
hip surgery
suggesting
Levine , 1991
enoxaparin
Unfractionated heparin
hip surgery
negative
Samama 1, 1988
enoxaparin
unfractionated heparin
general surgery
negative
∞%
-1%
Samama 2, 1988
enoxaparin
unfractionated heparin
general surgery
negative
∞%
∞%
Samama 3, 1988
enoxaparin
unfractionated heparin
general surgery
negative
∞%
-8%
Kaaja, 1992
enoxaparin
unfractionated heparin
gynaecological surgery
-
Gazzaniga (ISG), 1993
enoxaparin
unfractionated heparin
general surgery
-
Nurmohamed, 1995
enoxaparin
unfractionated heparin
general surgery
-
McLeod (Canadian), 1995
enoxaparin
unfractionated heparin
abdominal surgery
-
Gonzalez, 1996
enoxaparin
unfractionated heparin
abdominal surgery
-
ENOXACAN, 1997
enoxaparin
unfractionated heparin
abdominal surgery
-
fraxiparin
Pezzuoli, 1989
nadroparin
placebo
suggesting
-55%
151%
Leyvraz, 1991
nadroparin
Unfractionated heparin
hip surgery
negative
-49%
LMWH
Harenberg, 1990
LMWH
UFH
medical patients
Low risk of bias
negative
193%
Harenberg, 1996
LMWH
UFH
medical patients
Low risk of bias
negative
146%
nadroparin
Yoo, 1997
nadroparin
no treatment
hip surgery
negative
Marassi [41]
nadroparin
no treatment
negative
Sourmelis, 1995
nadroparin
placebo
hip surgery
Low risk of bias
suggesting
Balas [40]
nadroparin
placebo
negative
Nurmohamed, 1996
nadroparin
placebo
negative
Fraisse, 2000
Nadroparin
placebo
medical patients
Low risk of bias
negative
5%
109%
Mahe, 2005
Nadroparin
placebo
medical patients
Low risk of bias
negative
-2%
-66%
Bergmann, 1996
nadroparin
placebo
medical patients
negative
-2%
Kakkar and Murray, 1985
nadroparin
unfractionated heparin
general surgery
suggesting
-17%
EFS, 1988
nadroparin
unfractionated heparin
abdominal surgery
suggesting
-11%
Dahan, 1989
nadroparin
unfractionated heparin
thoracic surgery
negative
Barbui, 1990
nadroparin
unfractionated heparin
general surgery
-
Eurin, 1994
nadroparin
unfractionated heparin
abdominal surgery
-
reviparin
Kakkar, 1993
reviparin
unfractionated heparin
general surgery
-
tinzaparin
Lassen, 1991
tinzaparin
placebo
hip surgery
Low risk of bias
suggesting
13%
Bergqvist [42]
tinzaparin
placebo
negative
-100%
∞%
Leizorovicz, 1991
tinzaparin
unfractionated heparin
abdominal surgery
-
UFH
Cerrato, 1978
UFH
no treatment
suggesting
venous thrombosis
Bemiparin
Kakkar, 2003
Bemiparin
warfarin
Risk of bias
negative
dalteparin
Das, 1996
Dalteparin
warfarin
Risk of bias
negative
Lee, 2003
Dalteparin
warfarin
Risk of bias
suggesting
Holmström, 1992
once daily dalteparin
twice daily dalteparin
negative
Partsch, 1996
once daily dalteparin
twice daily dalteparin
negative
153%
Bratt et al , 1985
Dalteparin
unfractionated heparin
negative
Holm et al , 1986
Dalteparin
unfractionated heparin
negative
Bratt et al, 1990
Dalteparin
unfractionated heparin
negative
83%
Lindmarker et al , 1993
Dalteparin
unfractionated heparin
negative
-32%
enoxaparin
Veiga, 2000
Enoxaparin
acenocoumarol
Risk of bias
negative
González-Fajardo, 2008
Enoxaparin
coumarin
Risk of bias
-
Pini, 1994
Enoxaparin
warfarin
Risk of bias
negative
Gonzalez-Fajardo, 1999
Enoxaparin
warfarin
Risk of bias
suggesting
Meyer, 2002
Enoxaparin
warfarin
Risk of bias
negative
Deitcher, 2003
Enoxaparin
warfarin
Risk of bias
negative
Merli, 2001
once daily enoxaparin
twice daily enoxaparin
Low risk of bias
negative
65%
Merli (once daily vs UFH), 2001
once daily enoxaparin
UFH
Low risk of bias
negative
19%
Simonneau et al , 1993
Enoxaparin
unfractionated heparin
negative
50%
logiparin
Siegbahn, 1989
once daily logiparin
twice daily logiparin
negative
nadroparin
Lopaciuk, 1999
Nadroparin
acenocoumarol
Risk of bias
negative
Lopez-Beret, 2001
Nadroparin
acenocoumarol
Risk of bias
negative
Charbonnier, 1998
once daily nadroparin
twice daily nadroparin
Low risk of bias
negative
-27%
Collaborative European Multicentre, 1991
Nadroparin
unfractionated heparin
negative
89%
Prandoni et al , 1992
Nadroparin
unfractionated heparin
suggesting
-50%
Lopaciuk et al , 1992
Nadroparin
unfractionated heparin
negative
-100%
tinzaparin
Romera, 2009
Tinzaparin
acenocoumarol
Risk of bias
suggesting
Hull, 2002
Tinzaparin
warfarin
Risk of bias
negative
Hull et al , 1992
Tinzaparin
unfractionated heparin
suggesting
-51%
×
Modal title